Drug
Epidiolex 100 mg/mL Oral Solution
Epidiolex 100 mg/mL Oral Solution is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_1
2
40%
Ph phase_4
1
20%
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Completed2
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (50.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
Trials by Status
completed240%
recruiting120%
not_yet_recruiting240%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingphase_4
A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
NCT06924827
recruiting
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT05485831
not_yet_recruitingphase_3
Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
NCT07148206
completedphase_1
Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
NCT04721691
completedphase_1
CBD for Dental Pain
NCT04642404
Clinical Trials (5)
Showing 5 of 5 trials
NCT06924827Phase 4
A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
NCT05485831
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT07148206Phase 3
Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
NCT04721691Phase 1
Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
NCT04642404Phase 1
CBD for Dental Pain
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5